| NCT06199531 | Safety and Efficacy of GS-100 Gene Therapy in Patients With NGLY1 Deficiency | RECRUITING | PHASE1, PHASE2 | 2024-02-13 | 2028-01-31 | 2028-01-31 |
| NCT05849844 | Tympanoseal Clinical Study | RECRUITING | NA | 2024-01-05 | 2026-04-20 | 2026-04-20 |
| NCT05995405 | Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAH | ACTIVE_NOT_RECRUITING | PHASE3 | 2023-10-20 | 2024-12 | 2024-12 |
| NCT05531890 | Comparative Bioavailability of Betamethasone Oral Solution Metered Spray (GTX-102) in Healthy Subjects | UNKNOWN | PHASE1 | 2022-09-13 | 2023-05-03 | 2022-11-24 |
| NCT05517486 | Single-dose to Evaluate the Pharmacokinetics of GTX-101 and Subcutaneous Injectable Bupivacaine in Healthy Subjects | UNKNOWN | PHASE1 | 2022-07-26 | 2023-05-03 | 2022-08-21 |
| NCT05418348 | Relative Bioavailability of Intravenous GTX-104 Compared to Oral Nimodipine Capsules in Healthy Subjects | COMPLETED | PHASE1 | 2021-08-26 | 2022-02-24 | 2022-02-17 |
| NCT03361501 | A Phase 3 STudy of CaPRe in LOwering Very hiGh TriglYcerides (TRILOGY 2) | COMPLETED | PHASE3 | 2018-02-01 | 2020-01-09 | 2019-09-24 |
| NCT03398005 | A Phase 3 STudy of CaPRe In LOwering Very hiGh TriglYcerides (TRILOGY 1) | COMPLETED | PHASE3 | 2018-01-23 | 2019-11-20 | 2019-07-21 |
| NCT02918942 | Tympanoseal (Tympanic Membrane Device) Clinical Study | COMPLETED | | 2016-10-04 | 2021-09-30 | 2021-09-30 |
| NCT01516151 | Assess the Safety and Efficacy of NKPL66 (CaPreâ„¢) in the Treatment of Mild-to-high Hypertriglyceridemia | COMPLETED | PHASE2 | 2011-12 | 2013-09 | 2013-05 |
| NCT01455844 | TRIal For Efficacy of Capre on hyperTriglyceridemiA | COMPLETED | PHASE2 | 2011-09 | 2014-08 | 2014-06 |